Literature DB >> 11774403

Hypercalcemia associated with parathyroid hormone-related protein at the terminal stage of uncomplicated squamous cell carcinoma in the head and neck region.

Megumi Fujikawa1, Yutaka Takata, Ken Okamura, Mizuho Nakagawa, Akira Tateishi, Hideo Kurokawa, Kaori Sato, Jinichi Fukuda, Minoru Kajiyama, Masatoshi Fujishima.   

Abstract

BACKGROUND: Parathyroid hormone-related protein (PTHrP) is mainly responsible for hypercalcemia in squamous cell carcinomas (SCCs).
METHODS: We retrospectively checked the appearance of hypercalcemia among 33 patients who died with head and neck SCC. Serum concentrations of C-terminal region of PTHrP (C-PTHrP) were measured in 15 of them. The intracellular PTHrP expression was immunohistochemically stained in 42 SCC sections obtained from the 33 before the appearance of hypercalcemia.
RESULTS: Hypercalcemia appeared in 24 of the 33, and increased serum C-PTHrP levels were confirmed in 11 of 12 hypercalcemic patients. PTHrP was identified in all SCC sections, and a stronger intensity than in normal squamous epithelia was observed in 50% of those obtained within 1 year before the onset of hypercalcemia.
CONCLUSION: A high incidence of PTHrP-induced hypercalcemia was shown among patients dying with head and neck SCCs. The intracellular increase in PTHrP might be observed preceding hypercalcemia. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774403     DOI: 10.1002/hed.10008

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.

Authors:  Chelsea K Martin; Wessel P Dirksen; Sherry T Shu; Jillian L Werbeck; Nanda K Thudi; Mamoru Yamaguchi; Tobie D Wolfe; Kristin N Heller; Thomas J Rosol
Journal:  Oral Oncol       Date:  2012-01-21       Impact factor: 5.337

2.  Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.

Authors:  Chelsea K Martin; Jillian L Werbeck; Nanda K Thudi; Lisa G Lanigan; Tobie D Wolfe; Ramiro E Toribio; Thomas J Rosol
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.